The introduction of the first disease-modifying therapy for Alzheimer’s was a pivotal moment in medical history, yet it didn’t evoke the anticipated excitement within the community.
Despite its groundbreaking status, the reaction to the therapy highlighted a complex mix of hope and skepticism, as many experts debated its effectiveness and real-world applicability.
Collection
[
|
...
]